![Dirk Thye](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Thye
Chief Executive Officer at
QUINCE THERAPEUTICS, INC.
Net worth: 162 003 $ as of 2026-08-30
Profile
Dr. Dirk Thye, MD, is a CEO, Director & Chief Medical Officer at Quince Therapeutics, Inc. He is on the Board of Directors at Quince Therapeutics, Inc. Dr. Thye was previously employed as a Chief Executive Officer & Director by Novosteo, Inc., a President, CEO, CFO, Secretary & Director by Agenovir Corp., an Executive Chairman by Geom Therapeutics, Inc., a Chief Medical Officer by Cidara Therapeutics, Inc., a Founder by Pfluent, Inc., a Manager-Business Process by Quality Planning Corp, a Principal by Inclin, Inc., a President by Cerexa, Inc., and a Senior Vice President-Clinical Development by Peninsula Pharmaceuticals, Inc. He also served on the board at Kalyra Pharmaceuticals, Inc. He received his undergraduate degree from the University of California, Berkeley and a graduate degree from the University of California, Los Angeles.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-28 | 4,974 ( 0.49% ) | 162 003 $ | 2026-08-30 |
Dirk Thye active positions
| Companies | Position | Start |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Chief Executive Officer | 2022-05-18 |
Former positions of Dirk Thye
| Companies | Position | End |
|---|---|---|
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Chief Executive Officer | 2022-04-30 |
Geom Therapeutics, Inc.
 Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Founder | 2020-06-30 |
Agenovir Corp.
 Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Chief Executive Officer | 2017-12-31 |
| CIDARA THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2016-09-01 |
Pfluent, Inc. | Founder | 2014-02-28 |
Training of Dirk Thye
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Commercial Services |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures small molecule drugs | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quality Planning Corp
 Quality Planning Corp Insurance Brokers/ServicesFinance Provides analytic methods to insurance companies for auto insurance ratings | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inclin, Inc.
 Inclin, Inc. Miscellaneous Commercial ServicesCommercial Services Operates contract research organization and provides biometrics, clinical operations, strategic consulting, medical writing, quality assurance, drug safety and medical monitoring services | Commercial Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Agenovir Corp.
Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Health Technology |
Pfluent, Inc. | |
Geom Therapeutics, Inc.
Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Commercial Services |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
- Stock Market
- Insiders
- Dirk Thye
